Abstract:Objective: To employ Design of Experiment (DOE) for designing a floating matrix tablet of Domperidone Maleate (DM) using novel direct compression grade polymer METHOCEL K4M DC2 that offers advantages of extended or sustained release, providing for cost-effective manufacturing. Methods: To prepare floating matrix tablets containing DM, the direct compression method was employed. The tablets were optimised using a 22 Central Composite Design (CCD). Concentration of the sustained release polymer METHOCEL DC2 K4M grade (X1= A) and Concentration of the floating agent potassium bicarbonate (KHCO3) (X2= B) were the independent variables selected whereas floating lag time (Y1), drug release at 1 h (Y2), 4 h (Y3), 6 h (Y4) and 8 h (Y5) were the 5 dependent variables employed in the study design. Fourier Transform Infrared (FTIR) analysis was utilised to analyse drug-excipient compatibility, revealing no discernible interaction, and various mathematical models were employed to study the drug release mechanism. Results: The prepared tablets were evaluated for weight, thickness, hardness, friability, and assay and the results were found to be satisfactory. The optimised formulation predicted by the software was found to have a desirability value of 0.982, containing 60 mg of METHOCEL DC2 K4M and 20 mg of KHCO3, was prepared and evaluated. Predicted and experimental results were found to be comparable for all the responses. All formulations were shown to fit well into Zero-order release kinetics, but the optimised formulation (F4), with R2= 0.9893 and n= 2.2797, exhibited the best fitting in both the Zero-order and Korsmeyers-Peppas model. Conclusion: The study conducted revealed that floating tablets of DM could be developed using KHCO3 as a gas-generating agent with sustained drug release till 14 h using polymer METHOCEL DC2 K4M.

Optimization of Mirabegron Sustained-release Tablets by Central Composite Design-response Surface Meth-od

Study on pramipexole dihydrochloride sustained-release tablets

Optimization of pramipexole hydrochloride sustained-release tablets using Box-Behnken design and mechanism of in vitro drug release

Optimization of Sustained Release Matrix Tablet of Metoprolol Succinate Using Central Composite Design.

Optimization of Ambroxol Hydrochloride Sustained-Release Tablets Formulation by Central Composite Design-Response Surface Methodology

Optimization of the Formulation of Bezafibrate Osmotic Pump Tablets by Central Composite Design-response Surface Methodology

Unveiling Swelling and Erosion Dynamics: Early Development Screening of Mirabegron Extended Release Tablets

STATISTICAL DESIGN OF EXPERIMENT-BASED FORMULATION DEVELOPMENT AND OPTIMIZATION OF FLOATING MATRIX TABLET OF ANTI-EMETIC DRUG

Optimization of Compound Hydrochlorothiazide/clonidine Hydrochloride SUS-tained-release Preparation by Central Composite Design/response Surface Methodology

Intestinal Absorption Site-Guided Development and Evaluation of Oral Disintegrating Controlled Release Tablets of Mirabegron

Optimization of Coating Formulation of Memantine Hydrochloride Sus-tained -release Pellets by Central Composite Design -Response Surface Methodology

Full-factorial Desig n for Optimizing Formulation of Metformin Hydrochloride Extended-release Tablets and Investigation of Release Mechanism in Vitro

Optimization of Extended Zero-order Release Gliclazide Tablets Using D-optimal Mixture Design

Optimization of Breviscapin Sustainded Release Tablets by Mixture Uniform Design

Optimization of the Biphasic Release of Indomethacin from HPMC/pectin/calcium Chloride Matrix Tablet by Response Surface Methodology

Optimization of Levofloxacin Hydrochloride Sustained-release Tablets by Central Composite Design

Study of Tamsulosin Hydrochloride Sustained- Release Capsules Based on QbD Theory

Design of Experiment (DoE) Approach to Prepare, Characterize and Optimize the Gastroretentive Mucoadhesive Microspheres of Repaglinide

Formulation Optimization of Vitamin C Vaginal Bioadhesive Sustained-release Tablets by Central Composite Design

Preparation and in vitro Release of Doxazosin Mesylate Controlled-Release Tablets

Formulation Optimization of Zuojin Floating-Bioadhesive Pellets by Central Composite Design-Response Surface Methodology